2,996
Participants
Start Date
March 2, 2014
Primary Completion Date
June 22, 2019
Study Completion Date
August 31, 2020
In-Person Outcome Assessment
NIH Flexible Outcome Assessment Battery Framework Measures In-Person at 2 Weeks, 6 Months, and 12 Months, and by Phone at 3 Months.
Phone Outcome Assessment
NIH Flexible Outcome Assessment Battery Framework Measures by Phone at 2 Weeks, 3 Months, 6 Months, and 12 Months.
3T Magnetic Resonance Imaging (MRI)
3T Research MRI at 2 weeks and 6 months.
Blood Draw for Plasma, DNA, Serum, RNA
Blood Draw for Plasma, DNA, Serum, RNA at baseline, in hospital (if applicable), 2 weeks, and 6 months (DNA at baseline only).
University of Pittsburgh Medical Center, Pittsburgh
University of Pennsylvania/Penn Presbyterian Medical Center, Philadelphia
University of Maryland, Baltimore
Virginia Commonwealth University, Richmond
Emory University, Atlanta
University of Miami, Miami
University of Cincinnati, Cincinnati
Indiana University, Indianapolis
Medical College of Wisconsin, Milwaukee
University of Minnesota/Hennepin County Medical Center, Minneapolis
University of Texas Southwestern, Dallas
Baylor College of Medicine, Houston
TIRR Memorial Hermann, Houston
University of Texas Health Science Center at Houston, Houston
Dell Seton Medical Center, Austin
University of Texas at Austin, Austin
University of Colorado/Craig Hospital, Englewood
Denver Health and Hospitals Authority, Denver
University of Utah, Salt Lake City
University of California, San Francisco, San Francisco
University of Washington, Seattle
Massachusetts General Hospital, Boston
Spaulding Rehabilitation Hospital, Charlestown
National Institutes of Health (NIH)
NIH
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Department of Health and Human Services
FED
University of California, San Francisco
OTHER